Literature DB >> 59242

Inheritance in protoporphyria. Comparison of haem synthetase activity in skin fibroblasts with clinical features.

J R Bloomer, H L Bonkowsky, P S Ebert, M J Mahoney.   

Abstract

The activity of haem synthetase, the enzyme which chelates iron to protoporphyrin to form haem, was measured in cultured skin fibroblasts of children with protoporphyria and their parents from three families. In each family, one parent had deficient haem synthetase activity (3-0-11-1 pmol protohaem formed/mg protein/h) when compared to values in eight non-porphyric controls (means 24-9, range 13-7-51-5). The level of activity in the three parents was similar to that in their affected children. In two families the parent with deficient activity was also thought to be the carrier of the abnormal gene, as judged from a history of photosensitivity and analysis of erythrocyte protoporphyrin concentrations, but in the third family the pattern of inheritance could not be determined from these criteria. The activity of delta-aminolaevulinic acid synthetase was normal in cultured fibroblasts from the protoporphyric children and their parents, excluding a generalised defect in haem-pathway enzymes. These results support the premise that deficient haem synthetase activity, inherited in an autosomal dominant patter, is the primary defect in protoporphyria.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 59242     DOI: 10.1016/s0140-6736(76)91027-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria.

Authors:  Y Nakahashi; H Fujita; S Taketani; N Ishida; A Kappas; S Sassa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

Authors:  J R Bloomer; D A Brenner; M J Mahoney
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.

Authors:  S Tutois; X Montagutelli; V Da Silva; H Jouault; P Rouyer-Fessard; K Leroy-Viard; J L Guénet; Y Nordmann; Y Beuzard; J C Deybach
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

4.  A molecular defect in human protoporphyria.

Authors:  D A Brenner; J M Didier; F Frasier; S R Christensen; G A Evans; H A Dailey
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

5.  Characterization of deficient heme synthase activity in protoporphyria with cultured skin fibroblasts.

Authors:  J R Bloomer
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

6.  Heme content of normal and porphyric cultured skin fibroblasts.

Authors:  D A Brenner; J R Bloomer
Journal:  Biochem Genet       Date:  1977-12       Impact factor: 1.890

7.  Bovine protoporphyria: documentation of autosomal recessive inheritance and comparison with the human disease through measurement of heme synthase activity.

Authors:  J R Bloomer; K O Morton; R J Reuter; G R Ruth
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

8.  Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver.

Authors:  D L Avner; R G Lee; M M Berenson
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

Review 9.  Comparison of human and bovine protoporphyria.

Authors:  D A Brenner; J R Bloomer
Journal:  Yale J Biol Med       Date:  1979 Sep-Oct

10.  Pathogenesis and therapy of liver disease in protoporphyria.

Authors:  J R Bloomer
Journal:  Yale J Biol Med       Date:  1979 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.